Ceragon to Present at the 37th Annual Roth Conference: Insights into the Company’s Upcoming Business Developments

Ceragon’s CEO to Speak at 37th Annual Roth Conference Rosh Ha’Ain, Israel – March 3, 2025 – Ceragon (NASDAQ: CRNT), a prominent solutions provider in the field of end-to-end wireless connectivity, announced today that Doron Arazi, the company’s Chief Executive Officer, will participate in the 37th Annual Roth Conference. This conference is scheduled to take…

Read More

Thunder Gold Unveils Detailed 2025 Exploration and Drilling Strategy for Tower Mountain Gold Property

Thunder Gold Corp’s Tower Mountain Gold Property: Resuming Exploration in Thunder Bay, Ontario Thunder Gold Corp, a mineral exploration company, has recently announced the resumption of exploration activities at its 100%-owned Tower Mountain Gold Property, located in the Shebandowan Greenstone Belt, Thunder Bay, Ontario. The Property covers an area of 2,500 hectares and hosts the…

Read More

Pyxis Oncology’s Exciting Lineup: Heading to Leerink Partners’ Global Healthcare Conference!

Pyxis Oncology’s New Appointment: Lara S. Sullivan, M.D. Joins as Chief Medical Officer Boston, MA – March 03, 2025 Pyxis Oncology, a trailblazing clinical-stage biotech company specializing in the development of next-generation therapeutics for challenging cancers, proudly announced the appointment of Lara S. Sullivan, M.D., as their new Chief Medical Officer. Dr. Sullivan brings a…

Read More

Gannett to Present at Deutsche Bank’s 33rd Annual Media, Internet, and Telecom Conference: Insights from the Event

Gannett’s CFO to Speak at Deutsche Bank Conference: A Look into the Company’s Plans New York, NY – In an exciting development for investors and industry observers, Gannett Co., Inc. (Gannett or the Company) has announced that its Chief Financial Officer, Doug Horne, will participate in the upcoming Deutsche Bank 33rd Annual Media, Internet &…

Read More

ImmunityBio Announces Sales Growth and Financial Results for 2024 Following Permanent J-Code Issuance in January 2025 for Product J9028

ImmunityBio’s Operational and Financial Updates: A New Era for Immunotherapy CULVER CITY, Calif. – ImmunityBio, Inc. (IBRX), a pioneering immunotherapy company, recently disclosed some intriguing operational and financial updates following the approval of the permanent J-code (J9028) in January 2025. This announcement marks a significant milestone for the company, leading to increased sales momentum and…

Read More

Rithm Capital Preferreds: A Profitable and Intense Investment Opportunity for Educated and Professional Investors

Exploring Rithm Capital Corporation: A Diversified mREIT with Preferred Stocks Rithm Capital Corporation, an experienced real estate investment trust (REIT) and financial services company, has recently garnered attention from investors with its impressive performance and diverse investment portfolio. This corporation has earned Buy and Strong Buy ratings from various financial analysts, making it an attractive…

Read More

Professor Jonathan Kolstad, Renowned Health Economics Expert, Joins Compass Lexecon

FTI Consulting Welcomes Health Economist Jonathan Kolstad to Compass Lexecon Washington D.C., March 3, 2025 – FTI Consulting, Inc. (NYSE: FCN), a global business solutions provider dedicated to helping organizations manage change, announced today that renowned health economist, Dr. Jonathan Kolstad, has affiliated with its economic consulting subsidiary, Compass Lexecon. About Dr. Jonathan Kolstad Dr….

Read More